Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Prospective Single-center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic Sclerosis

NCT05204784 is registered in ClinicalTrials.gov with Peter Korsten as lead sponsor.

NCT NCT05204784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05204784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Prospective Single-center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic Sclerosis
Lead sponsor
Peter Korsten
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2022
Completion date
June 30, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

digital ulcer, raynaud phenomenon, scleroderma, systemic sclerosis